Myovant Sciences Ltd 's

• MYOV's Stock Performance relative to its Competitors

Biofrontera Inc Share Performance -22.88% 30 Days

Biofrontera Inc Profile Biofrontera Inc is a pharmaceutical company that specializes in developing and commercializing dermatological treatments for various skin conditions. Their business model revolves around research and development to create innovative products, obtaining regulatory approvals, and marketing and selling their products globally through direct sales teams and distribution partnerships. They aim to provide patients with effective and safe dermatological treatments while generating revenues through product sales. More about Biofrontera Inc 's Market Share

Novan Inc Share Performance -46.84% Over The Past 5 Days

Novan Inc Profile Novan Inc is a biotechnology company that operates on a dermatology-focused business model. They develop and commercialize innovative therapies that address unmet medical needs in dermatology by utilizing their proprietary nitric oxide technology platform. Novan Inc primarily focuses on developing topical treatments for a range of skin conditions such as acne, atopic dermatitis, and fungal infections. More about Novan Inc 's Market Share

Opko Health Inc Share Performance +29.13% This Year

Opko Health Inc Profile Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies. More about Opko Health Inc 's Market Share

Allarity Therapeutics Inc Share Performance -34.81% One Year

Allarity Therapeutics Inc Profile Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles. More about Allarity Therapeutics Inc 's Market Share

Sunshine Biopharma Inc Share Performance -58.70% This Quarter

Sunshine Biopharma Inc Profile Sunshine Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing drugs for the treatment of cancer and other diseases. They utilize their expertise in drug discovery and development to create innovative treatments that target specific molecular targets in order to deliver more effective and personalized therapies for patients. More about Sunshine Biopharma Inc 's Market Share

Sources: Myovant Sciences Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 8:46 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Myovant Sciences Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.